WT1 and acute myeloid leukemia: They exhibited platinum agent mutagenesis (from the Wilms relapse treatment), leukaemogenic drivers and somatic hits in WT1 (a truncating variant and subclonal chromosome 11p LOH), supporting a causative role of the germline WT1 mutation in the AML of this child.